Morgan Stanley’s Allied Healthcare Products AHPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1
Closed 8025
2022
Q3
$0 Sell
1
-8,052
-100% -$14.8K ﹤0.01% 8057
2022
Q2
$13K Sell
8,053
-7,628
-49% -$17.3K ﹤0.01% 7152
2022
Q1
$50K Buy
15,681
+15,379
+5,092% +$54.2K ﹤0.01% 6708
2021
Q4
$2K Buy
302
+202
+202% +$1.16K ﹤0.01% 7830
2021
Q3
$1K Hold
100
﹤0.01% 7859
2021
Q2
$0 Hold
100
﹤0.01% 7860
2021
Q1
$0 Sell
100
-734
-88% -$4.19K ﹤0.01% 7616
2020
Q4
$4K Sell
834
-23,657
-97% -$122K ﹤0.01% 6821
2020
Q3
$136K Buy
24,491
+19,096
+354% +$161K ﹤0.01% 5285
2020
Q2
$64K Sell
5,395
-338
-6% -$4.02K ﹤0.01% 5595
2020
Q1
$100K Buy
5,733
+5,483
+2,193% +$42.7K ﹤0.01% 5187
2019
Q4
$0 Hold
250
﹤0.01% 6841
2019
Q3
$0 Buy
+250
New +$382 ﹤0.01% 6835
2016
Q2
Sell
-6
Closed 6712
2016
Q1
$0 Sell
6
-1
-14% -$2 ﹤0.01% 6781
2015
Q4
$0 Buy
+7
New +$17 ﹤0.01% 6851
2015
Q3
Sell
-7
Closed 6770
2015
Q2
$0 Hold
7
﹤0.01% 6795
2015
Q1
$0 Hold
7
﹤0.01% 6699
2014
Q4
$0 Hold
7
﹤0.01% 6711
2014
Q3
$0 Hold
7
﹤0.01% 6697
2014
Q2
$0 Hold
7
﹤0.01% 6634
2014
Q1
$0 Buy
+7
New +$33 ﹤0.01% 6577

Other funds holding AHPI

Morgan Stanley's AHPI Position: Q4 2022 in Review

Morgan Stanley sold out of Allied Healthcare Products (AHPI) in Q4 2022, closing a stake of 1 share.

Morgan Stanley first reported a position in AHPI in Q1 2014 and held it in 21 quarters. The position peaked at $136K in Q3 2020. 12 funds tracked by Wall St. Rank hold AHPI as of Q4 2022.

  • Morgan Stanley reported no remaining Allied Healthcare Products position as of Q4 2022 after selling out during the quarter.
  • Morgan Stanley sold 1 Allied Healthcare Products share in Q4 2022.
  • Morgan Stanley first reported a position in Allied Healthcare Products in Q1 2014 and held it in 21 quarters.
  • Morgan Stanley's Allied Healthcare Products position peaked at $136K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Allied Healthcare Products as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.